QIR Suite
by Casis Cardiac Simulation & Imaging Software
510(k) K211611
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK211611 | Date30 Sep 2022 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- QIH
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The QIR Suite is a cardiac imaging software system designed for quantitative image reconstruction and analysis of cardiac magnetic resonance (CMR) data. It provides tools for assessing cardiac structure and function, enabling precise measurements of myocardial volume, mass, and ejection fraction to support diagnostic and clinical decision-making.
This software is supplied as a standalone application for use in radiology and cardiac imaging departments, requiring installation on a compatible computing platform. It is intended for single-use sessions per imaging study, with no indication of sterility or reusable components. The QIR Suite holds FDA 510(k) clearance under the Radiology advisory committee and is compliant with the EU Medical Device Regulation (MDR), with a product code of QIH.
Other devices from Casis Cardiac Simulation & Imaging Software
Questions
AI-generated answers, 18 Sep 2026
What clinical applications does the QIR Suite support in cardiac imaging?
The QIR Suite is designed for quantitative analysis of cardiac magnetic resonance (CMR) data, enabling precise assessments of cardiac structure and function. Clinicians can use it to measure myocardial volume, mass, and ejection fraction—key metrics for diagnosing and evaluating heart conditions, such as cardiomyopathies or ischemic heart disease. It’s particularly useful in radiology and cardiac imaging departments for diagnostic decision-making.
How is the QIR Suite supplied, and what system requirements are implied for use?
The QIR Suite is supplied as a standalone software application that must be installed on a compatible computing platform. Since it’s intended for single-use sessions per imaging study, it doesn’t include physical components like reusable or sterile hardware. Users will need a system capable of running the software, though exact hardware specifications (e.g., processor, RAM) aren’t detailed in the data.
Is the QIR Suite approved for use in both the U.S. and European markets, and how?
Yes, the QIR Suite holds FDA 510(k) clearance under the Radiology advisory committee (K211611) and is compliant with the EU Medical Device Regulation (MDR). The U.S. clearance was granted as substantially equivalent to a predicate device, while the MDR compliance ensures it meets EU safety and performance standards for medical software.
Does the QIR Suite include any reusable or sterile components, or is it intended for single-use?
The QIR Suite is explicitly described as a software-only solution for single-use sessions per imaging study. Since it lacks physical components like reusable probes or sterile hardware, there are no sterility considerations or reuse requirements—only the software installation on a dedicated system.